The Claim
In adults with mild COVID-19, nitric oxide nasal spray (NONS) reduces the area under the curve of SARS-CoV-2 RNA load by -5.22 (95% CI, -9.14 to -1.31) over 6 days compared to placebo, indicating sustained virological suppression throughout the treatment period.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A nasal spray with nitric oxide helps people with mild COVID-19 by reducing the amount of virus in their body over a week of treatment, making them less sick.
See the scientific wording
Nitric oxide nasal spray (NONS) reduces the area under the curve of SARS-CoV-2 RNA load by -5.22 (95% CI, -9.14 to -1.31) over 6 days in adults with mild COVID-19 compared to placebo, indicating sustained virological suppression throughout the treatment period.
Score breakdown, mechanism chain, raw evidence, ideal studies needed
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.